Cargando…

TRIP 13-dependent pathways promote the development of gastric cancer

TRIP13 is highly expressed in various human tumors and promotes tumorigenesis. We aimed to explore the biological effect of TRIP13 on gastric cancer. The RNA sequence data were retrieved from TCGA to evaluate TRIP13 mRNA expression in gastric cancer. Paired formalin-fixed paraffin-embedded blocks we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Fengming, Liu, Xinmin, Xia, Yan, Zhu, He, Li, Fudong, Zhang, Nan, Xu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335954/ https://www.ncbi.nlm.nih.gov/pubmed/37432513 http://dx.doi.org/10.1007/s10142-023-01160-7

Ejemplares similares

Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway
por: Lu, Rujian, et al.
Publicado: (2021)

TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
por: Sheng, Nengquan, et al.
Publicado: (2018)

Disassembly of the Shieldin Complex by TRIP13
por: Sarangi, Prabha, et al.
Publicado: (2020)

TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma
por: Lu, Wang, et al.
Publicado: (2022)

Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways
por: Lan, Jin, et al.
Publicado: (2022)

Trip and Trip Pro
por: Fox, Lynne M.
Publicado: (2018)

Targeting TRIP13 for overcoming anticancer drug resistance (Review)
por: Zhao, Liwen, et al.
Publicado: (2023)

KIF18B promotes breast cancer cell proliferation, migration and invasion by targeting TRIP13 and activating the Wnt/β-catenin signaling pathway
por: Liu, Lan, et al.
Publicado: (2022)

Osimertinib induces paraptosis and TRIP13 confers resistance in glioblastoma cells
por: Hu, Lulu, et al.
Publicado: (2023)

TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway
por: Xiao, Zhangxian, et al.
Publicado: (2023)

TRIP6 functions as a potential oncogene and facilitated proliferation and metastasis of gastric cancer
por: Zhu, Lirong, et al.
Publicado: (2019)

TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status
por: Agarwal, Sumit, et al.
Publicado: (2020)

Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway
por: Gao, Yanjun, et al.
Publicado: (2019)

HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc
por: Li, Zhipeng, et al.
Publicado: (2021)

TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis
por: Zhang, Guanghui, et al.
Publicado: (2019)

Insights into a Crucial Role of TRIP13 in Human Cancer
por: Lu, S., et al.
Publicado: (2019)

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway
por: Wang, Yingcong, et al.
Publicado: (2023)

TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017)

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer
por: Banerjee, Rajat, et al.
Publicado: (2014)

TRIP13(PCH-2) promotes Mad2 localization to unattached kinetochores in the spindle checkpoint response
por: Nelson, Christian R., et al.
Publicado: (2015)

p31(comet) promotes homologous recombination by inactivating REV7 through the TRIP13 ATPase
por: Sarangi, Prabha, et al.
Publicado: (2020)

Molecular mechanisms of assembly and TRIP13-mediated remodeling of the human Shieldin complex
por: Xie, Wei, et al.
Publicado: (2021)

Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity
por: Hama, Taketsugu, et al.
Publicado: (2021)

Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer
por: Banerjee, Rajat, et al.
Publicado: (2016)

ICARUS trip
por: Caraban Gonzalez, Noemi, et al.
Publicado: (2017)

Trip to the pore
por: Wells, William A.
Publicado: (2006)

The Trip to Busrah
Publicado: (1916)

Trip East
Publicado: (1863)

The Wedding Trip
Publicado: (1887)

Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker
por: Chen, Ssu-Han, et al.
Publicado: (2021)

Analyzing time-varying trip distributions with a random-effect spatial OD dependence model
por: Ni, Linglin, et al.
Publicado: (2023)

Understanding individual-level travel behavior changes due to COVID-19: Trip frequency, trip regularity, and trip distance
por: Lee, Sujin, et al.
Publicado: (2023)

Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma
por: Xu, Haojun, et al.
Publicado: (2022)

Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2‐Dependent Mitotic Cell Death
por: Rios Garcia, Marcos, et al.
Publicado: (2022)

Discovery trips in Mexico
Publicado: (1955)

Adverture trip guide.
Publicado: (1972)

A trip to the ER
por: LeBrasseur, Nicole
Publicado: (2002)

Dynein's spindly trip
por: LeBrasseur, Nicole
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_amrajhiad93le45aheqj6eoua8